Successful use of omalizumab in an inadequately controlled type 2 diabetic patient with severe insulin allergy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes care 2012-06, Vol.35 (6), p.e41-e41
Hauptverfasser:	Cavelti-Weder, Claudia, Muggli, Bettina, Keller, Cornelia, Babians-Brunner, Andrea, Biason-Lauber, Anna, Donath, Marc Y, Schmid-Grendelmeier, Peter
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Allergic Agents - administration & dosage Antibodies, Anti-Idiotypic - administration & dosage Antibodies, Monoclonal, Humanized - administration & dosage Blood Glucose - metabolism Diabetes Care Electronic Pages Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - physiopathology Humans Immunoglobulin E - blood Insulin - adverse effects Insulin - immunology Male Middle Aged Omalizumab Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!